Abstract
Multicellular tumour spheroids of the EMT6 mouse tumour line have been grown in a static (i.e. non-spinner) culture system to a mean spheroid diameter of 250 mum. Samples of spheroids were then exposed for 1 h to graded concentrations of various cytotoxic drugs, and the response assayed by both growth delay and survival of clonogenic cells. For nitrogen mustard (HN2), melphalan, BCNU, CCNU and cis-platinum, a considerable recovery in measured cell survival was seen if correlation between growth delay and cell survival (measured at 24 h) was observed for these 5 agents. For adriamycin, actinomycin D and 5-fluorouracil, no increase in measured cell survival was seen for a 24h delay in assay, and these agents produced longer growth delays for a given level of cell kill.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Twentyman, P. Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival. Br J Cancer 42, 297–304 (1980). https://doi.org/10.1038/bjc.1980.230
Issue Date:
DOI: https://doi.org/10.1038/bjc.1980.230
This article is cited by
-
Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer
Breast Cancer Research (2007)
-
A non-parametric method for the analysis of experimental tumour growth data
Medical & Biological Engineering & Computing (1999)
-
The activity of deoxyspergualin in multidrug-resistant cells
Cancer Chemotherapy and Pharmacology (1995)
-
Chemosensitisation of a drug-sensitive parental cell line by low-dose cyclosporin A
Cancer Chemotherapy and Pharmacology (1991)
-
Effects of131I-labeled TNT-1 radioimmunotherapy on HT-29 human colon adenocarcinoma spheroids
Cancer Immunology Immunotherapy (1991)